BIIB033 (anti-LINGO-1 mAb) [clinicaltrials_resource:f86e6f67a3d673f62625f880b25aec5a]
intervention [clinicaltrials_vocabulary:intervention]
BIIB033 (anti-LINGO-1 mAb) [clinicaltrials_resource:f86e6f67a3d673f62625f880b25aec5a]
Bio2RDF identifier
f86e6f67a3d673f62625f880b25aec5a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f86e6f67a3d673f62625f880b25aec5a
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
100 mg/kg via IV infusion once every 4 weeks for 20 weeks (a total of 6 doses).
intervention name [clinicaltrials_vocabulary:intervention-name]
BIIB033 (anti-LINGO-1 mAb)
other name [clinicaltrials_vocabulary:other-name]
anti-LINGO-1 mAb
identifier
clinicaltrials_resource:f86e6f67a3d673f62625f880b25aec5a
title
BIIB033 (anti-LINGO-1 mAb)
@en
type
label
BIIB033 (anti-LINGO-1 mAb) [clinicaltrials_resource:f86e6f67a3d673f62625f880b25aec5a]
@en